Evolus, Inc. (NASDAQ:EOLS) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET
Company Participants
David Erickson - Vice President of Investor Relations
David Moatazedi - President and Chief Executive Officer
Rui Avelar - Chief Medical Officer and Head of Research and Development
Sandra Beaver - Chief Financial Officer
Conference Call Participants
Annabel Samimy - Stifel, Nicolaus & Company, Inc.
Marc Goodman - SVB Securities
Douglas Tsao - H.C. Wainwright & Co.
Louise Chen - Cantor Fitzgerald & Co.
Navann Ty - BNP Paribas Exane
Serge Belanger - Needham & Company, LLC
Gregory Fraser - Truist Securities, Inc.
Uy Ear - Mizuho Securities Co.
Operator
Greetings, and welcome to the Evolus Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, David Erickson, Vice President, Investor Relations. Thank you, David. You may begin.
David Erickson
Thank you, operator, and welcome to everyone joining us on today's call. With me today are David Moatazedi, President and Chief Executive Officer; Rui Avelar, Chief Medical Officer, Head of R&D; and Sandra Beaver, Chief Financial Officer.
Our prepared remarks today will include forward-looking statements within the meaning of United States Securities Laws, and management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the Company's business, strategy, operations or financial performance. A detailed discussion of the risks and uncertainties that the Company faces is contained in its annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
Actual results may differ materially from those expressed in or implied by the forward-looking statements. The Company undertakes no obligation to update or review any estimate, projection or forward-looking statements. Additionally, today's discussion will include non-GAAP financial measures, which should be considered in addition to and not as a substitute for or in isolation from our GAAP results. A reconciliation of GAAP to non-GAAP results may be found in our earnings release, which was furnished with our Form 8-K filed today with the SEC and on our Investor Relations website at evolus.com. Lastly, following the conclusion of today's call, a replay will be available on our website at evolus.com.